Lectures/Seminars: Lectures: Panel about vaccination. 8 th midyear - - PDF document

Lectures/Seminars: Lectures:

• Panel about vaccination. 8th midyear conference of infectious diseases.

Babolsar, Iran (2009).

• Panel about Brucellosis treatment in 7th midyear conference of infectious
• diseases. Isfahan, Iran (2008).
• Panel about Hepatitis in 6th midyear conference of infectious diseases.

Babolsar 16-19 Oct 2007.

• Panel about Hepatitis in 5th midyear conference of infectious diseases

Babolsar 1-2 Nov 2006.

• Panel about antimicrobial resistance in 5th midyear conference of

infectious diseases Babolsar 1-2 Nov 2006

• Lecture about nosocomial infection in midyear conference of infectious
• diseases. Babolsar, 27-29 Sep. 2005
• Lecture about epidemiology of animal bites in Tehran province in seminar
• f surveillance, treatment, prophylaxis for Rabies held in Pasteur Institute
• f Iran, 2005
• Lecture about vaccination in midyear conference of infectious diseases.

Shiraz, 6 -7 Oct. 2004

• Panel about Exantematouse disease in 2nd Iranian Congress of Virology in

Imam Khomeini Hospital, 2004

• Lecture about apoptosis in liver cell due to drug toxin for general

physician in Mostafa Khomeini Hospital, 2004

Seminars

• Ramezani A, Eslamifar A, Razeghi E, Ahmadi F, Banifazl M and Aghakhani
• A. Occult Hepatitis C Virus Infection among Iranian Hemodialysis Patients.

24th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain (2014)

• Ramezani A, Banifazl M , Eslamifar A, Razeghi E, Ahmadi F, Amini M,

Keyvani H and Aghakhani A. No Evidence of Occult HCV infection in Hemodialysis Patients with Elevated Liver Enzymes. 22nd Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2014)

• Aghakhani A, Hamkar R, Eslamifar A, Bidari-Zerehpoosh F, Sabeti S,

Ghavami N, Banifazl M , Ramezani A. No Evidence of Human Papillomavirus Infection in the Etiology of Colon Adenocarcinamas and

• Adenomas. 15th Annual Congress of Iranian Society of Pathology, Tehran,

Iran (2013)

• Sofian M, Shams M, Aghakhani A, Banifazl M, Eslamifar A, ….. and

Ramezani A. Hematological Reference Ranges for Healthy Adult Males in the Central province of Iran.15th Annual Congress of Iranian Society of Pathology, Tehran, Iran (2013)

• Eslamifar A, Ramezani A, Banifazl M, ….. and Aghakhani A. Immunity to

Diphtheria and Tetanus among Blood Donors in a Central Iranian City. 15th Annual Congress of Iranian Society of Pathology, Tehran, Iran (2013)

• Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Mashayekhi P

and Aghakhani A. Seroepidemiology of Hepatitis E Virus infection in Blood Donors of Central Province of Iran. 15th Annual Congress of Iranian Society

• f Pathology, Tehran, Iran (2013)

• Sofian M, Janbakhsh A, Aghakhani A, Banifazl M , Gol-Mohammadi M,

Eslamifar A, ……and Ramezani A. Immunogenicity of one Intradermal or Intramuscular Booster Vaccination Dose in HIV Infected individuals who failed to Standard Vaccination. 15th Annual Congress of Iranian Society of Pathology, Tehran, Iran (2013)

• Sofian M, Aghakhani A, Amir-Moezzi R , Zarinfar N, Banifazl M, Eslamifar

A and Ramezani A. Prevalence of HIV, HCV and HBV Infections and Associated Risk Factors among Injecting Drug Users in Arak City. 21st Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2013)

• Sofian M, Sheikholeslami M, Sarmadian H, Mahdaviani F, Aghakhani A,

Eslamifar A, Deiri GH, Ramezani A. Seroprevalence of Brucellosis Antibodies in Blood Donors in Central Province of Iran. 21st Iranian congress

• n infectious diseases and tropical medicine, Tehran, Iran (2013)
• Ramezani A, Mohraz M, Eslamifar A, Banifazl M, ….. and Aghakhani A.

Hepatitis E virus co-infection in HIV infected patients. 21st Iranian congress

• n infectious diseases and tropical medicine, Tehran, Iran (2013)
• Aghakhani A, Aghasadeghi MR, Banifazl M, Eslamifar A, …..and Ramezani
• A. Occult Hepatitis B Virus Infection in Hemodialysis Patients. 21st Iranian

congress on infectious diseases and tropical medicine, Tehran, Iran (2013)

• Sofian M, Safaeipour L, Aghakhani A, Banifazl M, Eslamifar A, Farazi A,

Didgar F, Ramezani A. Importance of Family Members Screening of Cases with Acute Brucellosis. 21st Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2013)

• Ramezani A, Eslamifar A, Banifazl M, Ahmadi F, Aghakhani A. Follow up of

Hemodialysis Patients with Occult Hepatitis B Virus Infection. 21st Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2013)

• Ramezani A, Aghasadeghi M, Bahramali G, Aghakhani A, Banifazl M, …….

Eslamifar A, Siadat S, Mohraz M. Frequency of hepatitis D virus infection in HIV-positive and haemodialysis patients in Iran. 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), London, UK (2012)

• Soufian S, Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M.

Reduction in interleukin-2 serum levels but lack of evidence of the Th1 to Th2 cytokine shift during the course of HIV infection. 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), London, UK (2012)

• Ramezani A, Sofian M, Aghakhani A, Farazi A, Banifazl M,. Eslamifar A,

Velayati A. Serum profile of T helper 1 and T helper 2 cytokines in HCV- infected patients. 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), London, UK (2012)

• Sofian M , Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, …..

Comparison of Brucella Induced epididymo-orchitis with Nonspecific Epididymo-orchitis in an Endemic Area for Brucellosis. 20th Iranian congress

• n infectious diseases and tropical medicine, Tehran, Iran (2011)
• Ramezani A, Sofian M, Aghakhani A ,…. Banifazl M, Eslamifar A, …..

Serum Profile of T helper 1 and T helper 2 Cytokines in HCV Infected

• Patients. 20th Iranian congress on infectious diseases and tropical medicine,

Tehran, Iran (2011)

• Ramezani A, Aghasadeghi MR, Bahramali G, Aghakhani A, Banifazl M,

…..Eslamifar A, ….. Frequency of hepatitis D virus infection in HIV positive and hemodialysis patients in Iran. 20th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2011)

• Ramezani A, Aghakhani A, Banifazl M, Forough M, Eslamifar A and Mohraz
• M. Seroprevalence of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and

HTLV-2 Infection in HIV Infected Patients. 20th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2011)

• Ramezani A, Sofian M, Banifazl M, Aghakhani A,….. Eslamifar A, …..

Evaluation of Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B Virus Infection Outcome. 20th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2011)

• Eslamifar A, Ramezani A, Mohraz M, Banifazl M, Forough M and Aghakhani
• A. Tetanus and diphtheria seroprevalence in HIV infected patients. 20th

Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2011)

• Ramezani A, ….., Aghakhani A, Soufian S, Eslamifar A and Banifazl M.

Mutations in the S gene region of hepatitis B virus in High Risk Patients with Occult HBV Infection. 20th ECCMID, Vienna, Austria (2010)

• Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A and Ramezani A.

Distribution of pertussis antibodies among Iranian children of different age

• groups. 20th ECCMID, Vienna, Austria (2010)
• Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M and Ramezani
• A. The Role of Human Papillomavirus Infection in Prostate Carcinoma. 14th

ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of

isolated antibody to hepatitis B core antigen in HIV- HCV coinfected

• individuals. 14th ICID - Miami, Florida, USA (2010)
• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Association of

polymorphism of HLA-DRB1 13 and HLA-A 33 alleles with outcome of hepatitis B virus infection. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. No evidence of
• ccult hepatitis B virus infection among anti-HBc-positive blood donors in an

area of low endemicity for HBV. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of occult

hepatitis B virus infection in HIV infected patients. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. The

epidemiology of tuberculosis in Arak city, Central province of Iran from 1997-

• 2007. 14th ICID - Miami, Florida, USA (2010)
• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Anti-HBs titers in

vaccinated children and adolescents: Implication for booster administration. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, Banifazl M,…….. Eslamifar A,… Aghakhani A. Prevalence of

Occult Hepatitis B Infection in Iranian Injection Drug Users. 14th ICID - Miami, Florida, USA (2010)

• Eslamifar A, Ramezani A, Banifazl M, Bidari F, Moradi A and Aghakhani A.

Association of Human Papillomavirus and Breast Carcinoma.19th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2010)

• Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Banifazl M. Occult and

chronic hepatitis B, hepatitis C, and HIV infections and co-infections among injection drug users. 19th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2010)

• Ramezani A, Mohraz M, Aghakhani A, ….. Eslamifar A, …. Genotype

characterization of hepatitis G virus isolates from Iranian patients infected with human immunodeficiency virus. 19th ECCMID, Helsinki, Finland(2009)

• Ramezani A, Aghakhani A, Mohraz M, Eslamifar A, Khadem-Sadegh A,

Banifazl M. Occult hepatitis B virus infection in “anti-HBc alone” haemodialysis patients. 19th ECCMID, Helsinki, Finland(2009)

• Sofian M, Ramezani A, ….. Aghakhani A, Eshrati B, Eslamifar A, Banifazl
• M. Predictive value of purified protein derivative in pulmonary tuberculosis in

a high BCG-vaccinated population. 19th ECCMID, Helsinki, Finland(2009)

• Aghakhani A, Hamkar R, …Eslamifar A,….Ramezani A. Identification of

hepatitis B virus genotype in patients with hepatocellular carcinoma in Iran.19th ECCMID, Helsinki, Finland (2009)

• Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani

A.Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis B Virus Infection. The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran (2009)

• Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Khadem-Sadegh A and

Ramezani A. Frequency of isolated antibody to hepatitis B core antigen in HIV- HCV coinfected individuals. The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran (2009)

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A,……Hamkar
• R. Frequency of Occult Hepatitis B Virus Infection and its Surface Mutants in

HIV Positive Patients. The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran (2009)

• Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Izadi N, Banifazl M.

Occult hepatitis B virus infection in blood donors with isolated anti-HBc. 18th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2009).

• Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M, Ramezani A.

Association of Human Papillomavirus with Prostate Cancer. 18th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2009).

• Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A, Ramezani A.

Seroepidemiology of pertussis antibodies among children of different age

• groups. 18th Iranian congress on infectious diseases and tropical medicine,

Tehran, Iran (2009).

• Ramezani A, Mohraz M, Hamkar R, Aghakhani A, Eslamifar A, Soufian S,

Banifazl M. Hepatitis B virus Surface Gene Mutations in High Risk Patients with Occult HBV Infection. 18th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2009).

• Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl M.

Age specific seroprevalence of hepatitis A antibody: Implications for health

• policy. 18th Iranian congress on infectious diseases and tropical medicine,

Tehran, Iran (2009).

• Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl M.

Seroprevalence of hepatitis B surface antibody in children subjected to the

Expanded Programme on Immunization (EPI). 18th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2009).

• Ramezani A, Mohraz M, Vahabpour R, …, Eslamifar A, Mahboudi F,

Aghakhani A, Edalat R, Hekmat S. Hepatitis G virus infection in patients infected with the human immunodeficiency virus. 13th ICID - Kuala Lumpur, Malaysia (2008)

• Ramezani A,…… Eslamifar A,…..Taeb J, Aghakhani A….. Association

between HLA-A, B, DRB1 alleles and susceptibility or resistance to chronic hepatitis B. 13th ICID - Kuala Lumpur, Malaysia (2008)

• Ramezani A, Mohraz M,…. Aghakhani A, Eslamifar A…. Prevalence of

Metabolic abnormalities in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy and antiretroviral-naive patients. 13th ICID - Kuala Lumpur, Malaysia (2008)

• Ramezani A, Eslamifar A, Mohraz M,….. and Aghakhani A. Long term

Immune response to hepatitis B vaccine in hemodialysis patients. 13th ICID - Kuala Lumpur, Malaysia (2008)

• Ramezani A,… Eslamifar A,……and Aghakhani A. Comparison of IFN-

gamma assay and Tuberculin Skin Test for detecting latent tuberculosis infection in BCG-vaccinated population. 13th ICID - Kuala Lumpur, Malaysia (2008)

• Eslamifar A, Aghakhani A ,Ramezani A,……. The role of fungi in the

etiology of chronic rhinosinusitis. 12th International Congress of Mycology. Istanbul, Turkey(2008)

• Aghakhani A, Hamkar R,…….Eslamifar A,…..Ramezani A. Genotype

Characterization of Hepatitis B Virus Isolates from Iranian Patients with

Hepatocellular Carcinoma . 10th annual congress of pathology and 4th annual congress of Iranian cancer association, Tehran, Iran (2008).

• Eslamifar A,…. Ramezani A,….and Aghakhani A. Frequency of Fungi and

Eosinophilic Granulocytes in Chronic Rhinosinusitis . 10th annual congress of pathology and 4th annual congress of Iranian cancer association, Tehran, Iran (2008).

• Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.

Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis B Virus Infection. 17th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2008).

• Ramezani A, Mohraz M,….. Aghakhani A,… Eslamifar A and Velayati AA.

Genotype characterization of hepatitis G virus isolates from Iranian patients infected with human immunodeficiency virus (HIV). 17th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2008).

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-

Sadegh A, Velayati AA. Frequency of isolated antibody to hepatitis B core antigen in HIV- HCV coinfected individuals. 17th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2008).

• Ramezani A, Aghakhani A,…. Eslamifar A,… Association of polymorphism
• f HLA-DRB1*13 and HLA-A *33 alleles with outcome of hepatitis B virus
• infection. 17th Iranian congress on infectious diseases and tropical medicine,

Tehran, Iran (2008).

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Velayati
• AA. Frequency of occult hepatitis B virus infection in HIV infected patients.

17th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2008).

• Ramezani A, Aghakhani A, Eslamifar A, Khadem-Sadegh A, Banifazl M.

Occult hepatitis B virus infection in "anti-HBc alone" hemodialysis patients. 17th Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2008).

• Panel about Diagnosis and treatment of chronic Brucellosis and Brucellosis
• relapse. 7th midyear conference of infectious diseases. Isfahan, Iran (2008).
• M. Soofian, A. Ramezani, ......, A. Aghakhani, A. Eslamifar. Risk factors for

human brucellosis in Iran: a case control study. ECCMID-ICC, Munich, Germany(2007).

• Eslamifar A. ,Aghakhani A. ,Ramezani A,…… Prevalence of hepatitis G

exposure in patients on chronic dialysis. 21st European Congress of Pathology, Istanbul, Turkey (2007).

• A. Kariminia, Z. sharifnia, A. Aghakhani, M. Banifazl , A. Eslamifar,

M.Hazrati and A. Ramezani. Performance of QuantiFERON TB-G Test for detecting latent tuberculosis infection in BCG-vaccinated population. 16th Iranian congress on infectious diseases and tropical medicine, Tehran,Iran (2007).

• A.Ramezani, A.Eslamifar......and A.Aghakhani. Persistence of Hepatitis B

Vaccine Immunity in Hemodialysis Patients.16th Iranian congress on infectious diseases and tropical medicine, Tehran,Iran (2007).

• A.Ramezani,M.Mohraz,....A.Aghakhani,A.Eslamifar,... Frequency of hepatitis

B and hepatitis C virus infections in HIV infected subjects.16th Iranian congress on infectious diseases and tropical medicine, Tehran,Iran (2007).

• A.Ramezani,M.Mohraz,....A.Aghakhani,A.Eslamifar,...

Impact

• f

antiretroviral treatment on lipid profile in HIV infected patients. 16th Iranian congress on infectious diseases and tropical medicine, Tehran,Iran (2007).

• A.Ramezani,M.Mohraz,....A.Aghakhani,A.Eslamifar,...

Anemia in HIV- infected patients receiving highly active antiretroviral therapy. 16th Iranian congress on infectious diseases and tropical medicine, Tehran,Iran (2007).

• A.Ramezani.MR Hasanjani Roshan,...A.Eslamifar.....J, Taeb, A. Aghakhani....

Influence of HLA class І and II alleles on the outcome of hepatitis B virus

• infection. 16th Iranian congress on infectious diseases and tropical medicine,

Tehran,Iran (2007).

• A.Ramezani....... A.Eslamifar and A. Aghakhani. Detection of YMDD

mutation in Iranian chronic hepatitis B patients before lamivudine treatment. 9th annual congress of pathology and 3rd annual congress of Iranian cancer association, Tehran, Iran (2007).

• Esalamifar A, Aghakhani A, Hamkar R, Ramezani A....Frequency of Human

Papillomavirus Infection in Esophageal Squamous Cell Carcinoma of Iranian

• patients. 12th International Congress on Infectious Diseases, Lisbon,

Portugal (2006)

• Eslamifar A, Ramezani A....and Aghakhani A. Hepatitis G virus exposure in

dialysis patients. 8th annual congress of pathology and 2nd congress of

• ncology, Tehran, Iran (2006)

• Eslamifar A , Hamkar R, Ramezani A....and Aghakhani A. Role of human

papillomavirus infection in esophageal carcinoma.8th annual congress of pathology and 2nd congress of oncology, Tehran, Iran (2006)

• Eslamifar A, Aghakhani A, Ramezani A, et al. Epidemiology of Animal Bites

in Tehran.15th Iranian congress on infectious diseases and tropical medicine, Tehran,Iran (2006)

• Eslamifar A, Hamkar R, Ramezani ……and Aghakhani A. Hepatitis G virus

(HGV) Exposure in Dialysis Staff. 15th Iranian congress on infectious diseases and tropical medicine, Tehran,Iran (2006)

• Ramezani A , ………, Eslamifar A and Aghakhani A .YMDD mutants in

patients with chronic hepatitis B before treatment are not selected by lamivudine.15th Iranian congress on infectious diseases and tropical medicine, Tehran,Iran (2006)

• Eslamifar A, Hamkar R, Ramezani ……and Aghakhani A. Exposure to

Hepatitis GB Virus in Patients on Maintenance Hemodialysis. 15th Iranian congress on infectious diseases and tropical medicine, Tehran,Iran (2006)

• Ramezani A, Eslamifar A….Factors influencuing to hepatitis B virus

vaccination in hemodialysis patiens. XLIII ERA-EDTA Congres(Glasgow, United Kingdom, July 15-18,( 2006)

• Ramezani A, Eslamifar A….Frequency of Hepatitis G infection among Iranian

blood donors.12th international congress on infectious diseases, Lisbon ,Portugal(2006)

• Ramezani A ,Eslamifar A…Assesment of blood mercury levels in infants

exposed to vaccines containing thiomersal. 2nd international congress on infectious and tropical diseases in Oman( 2006)

• Ramezani A, Eslamifar A…Efficacy of hepatitis B vaccination schedule and

comparing to complete regimen hemodialysis patients of Iran.12th international congress on infectious diseases, Lisbon ,Portugal(2006)

• Gachkar L, Ramezani A, Eslamifar A, Hamkar R, Khoshbaten M, Hazrati M.

Frequency of hepatitis G infection among Iranian blood donors. 14th Congress

• f Infectious Disease on 17-21 Dec. (2005)
• Ramezani A, Mohraz M, Feiabadi M, Banifazl M, Eslamifar A, Velayati A.A.

Frequency of vancomycin resistant Enterococci faecium in hospitals of

• Tehran. 14th Congress of Infectious Disease on 17-21 Dec. (2005)
• Ramezani A, Eslamifar A, Hazrati Mb, Mohraz M. Factors influencing to

hepatitis B vaccination response in hemodialysis patients of Tehran (Iran). 14th Congress of Infectious Disease on 17-21 Dec. (2005)

• Eslamifar A .Case report of skull plasmocytic granulom and study Efficacy of

electron microscopy on diagnosis. Congress of Pathology. (2004)

• Ramezani A, Eslamifar A, Heidari L, Hosseini H, Hazrati M. Rates of scar

failure in children vaccinated with BCG. 13th Congress of Infectious Diseases.11-15 December. (2004)

• Eslamifar A, Ramezani A, Nazgooie F,Mafakheri M, Hosseini Z Naseri M.R.

Situation of MR vaccination on mass campaign project in persons referred to Pasteur Institute of Iran. 12th Congress of Infectious Diseases. (2003)